US Stock MarketDetailed Quotes
ONPH ONCOLOGY PHARMA INC
- 0.000100
- 0.0000000.00%
15min DelayClose May 17 16:00 ET
3.80KMarket Cap0.00P/E (TTM)
0.000100High0.000100Low213Volume0.000100Open0.000100Pre Close0.02Turnover0.00%Turnover Ratio0.00P/E (Static)37.96MShares1.05000052wk High0.00P/B3.80KFloat Cap0.00000152wk Low--Dividend TTM37.96MShs Float42.780000Historical High--Div YieldTTM0.00%Amplitude0.000001Historical Low0.000000Avg Price1Lot Size
ONCOLOGY PHARMA INC Key Stats
Quarterly+Annual
YOY
| (Q3)Dec 31, 2004 | (Q2)Sep 30, 2004 | (Q1)Jun 30, 2004 | (FY)Mar 31, 2004 | (Q4)Mar 31, 2004 | (Q3)Dec 31, 2003 | (Q2)Sep 30, 2003 | (Q1)Jun 30, 2003 | (FY)Mar 31, 2003 | (Q4)Mar 31, 2003 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 82.31%-81K | 99.85%-1K | 67.41%-88K | -38.50%-2M | -30,000.00%-598K | 0.87%-458K | -88.80%-674K | 56.94%-270K | 0.41%-1.44M | -96.77%2K |
| Net income from continuing operations | 84.66%-81K | 96.54%-15K | 52.02%-178K | -2.96%-1.57M | -26.63%-233K | 3.47%-528K | 15.10%-433K | -32.97%-371K | 22.09%-1.52M | 43.21%-184K |
| Operating gains losses | ---- | ---- | --60K | -464.86%-135K | -213.11%-138K | --0 | ---- | ---- | 825.00%37K | --122K |
| Depreciation and amortization | ---- | ---- | ---- | -79.49%81K | -86.36%12K | -78.79%21K | -80.00%21K | -73.79%27K | 15.84%395K | -9.28%88K |
| Other non cash items | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Change In working capital | --0 | 105.28%14K | -59.46%30K | -7.02%-381K | -895.83%-239K | 406.25%49K | -652.08%-265K | 120.33%74K | -328.21%-356K | -108.30%-24K |
| -Change in receivables | ---- | ---- | ---- | 238.18%152K | ---- | ---- | ---- | ---- | -137.67%-110K | ---- |
| -Change in payables and accrued expense | ---- | ---- | ---- | -668.57%-538K | ---- | ---- | ---- | ---- | 77.92%-70K | ---- |
| -Change in other current assets | ---- | ---- | ---- | 950.00%84K | ---- | ---- | ---- | ---- | -89.47%8K | ---- |
| -Change in other current liabilities | ---- | ---- | ---- | 57.07%-79K | ---- | ---- | ---- | ---- | -275.24%-184K | ---- |
| -Change in other working capital | ---- | ---- | -59.46%30K | ---- | ---- | 406.25%49K | -652.08%-265K | 120.33%74K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 82.31%-81K | 99.85%-1K | 67.41%-88K | -38.50%-2M | -30,000.00%-598K | 0.87%-458K | -88.80%-674K | 56.94%-270K | 0.41%-1.44M | -96.77%2K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 0 | 180.00%116K | 6,550.00%133K | 0 | 80.90%-17K | 0 | 55.11%-145K | 102.78%2K |
| Net PPE purchase and sale | --0 | ---- | ---- | 88.28%-17K | --0 | --0 | ---- | ---- | 55.11%-145K | 102.78%2K |
| Net other investing changes | ---- | ---- | ---- | --133K | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | --0 | 180.00%116K | 6,550.00%133K | --0 | 80.90%-17K | --0 | 55.11%-145K | 102.78%2K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 2,540.00%122K | 0 | 83K | 54,500.00%546K | 8,400.00%85K | -5K | 466K | 0 | -99.84%1K | -99.84%1K |
| Net issuance payments of debt | --122K | --0 | --83K | --85K | ---- | ---- | ---- | ---- | ---- | ---- |
| Net common stock issuance | ---- | ---- | ---- | 46,000.00%461K | --0 | ---5K | ---- | ---- | -99.84%1K | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 2,540.00%122K | --0 | --83K | 54,500.00%546K | 8,400.00%85K | ---5K | --466K | --0 | -99.84%1K | -99.84%1K |
| Net cash flow | ||||||||||
| Beginning cash position | -99.76%2K | -99.72%3K | -99.41%8K | -54.12%1.35M | -71.07%388K | -52.88%851K | -52.22%1.08M | -54.12%1.35M | -28.02%2.93M | -41.87%1.34M |
| Current changes in cash | 108.86%41K | 99.56%-1K | 98.15%-5K | 15.74%-1.34M | -7,700.00%-380K | 0.43%-463K | 49.55%-225K | 60.41%-270K | -39.30%-1.59M | -99.19%5K |
| End cash Position | -88.92%43K | -99.76%2K | -99.72%3K | -99.41%8K | -99.41%8K | -71.07%388K | -52.88%851K | -52.22%1.08M | -54.12%1.35M | -54.12%1.35M |
| Free cash flow | 82.31%-81K | 99.86%-1K | 67.41%-88K | -26.78%-2.02M | -30,000.00%-598K | 1.51%-458K | -54.93%-691K | 60.41%-270K | 10.27%-1.59M | 120.00%2K |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg